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ABSTRACT 
Brucella melitensis is the cause of brucellosis in sheep and goats resulting in abortion. 
Few cases of B. melitensis infection in goats have occurred in the United States over the last 
25 years. However, vigilance for brucellosis in goats must be maintained as it is in the 
bovine milk industry to ensure it is not introduced into the U.S. goat population. Diagnostic 
methods using serum have primarily been used for anti-brucellae antibody detection in goats. 
Collecting serum samples requires added labor for the producer and stress for the animal. A 
diagnostic test for specimens such as milk would therefore be advantageous. The objective 
of this study was to develop a sensitive and specific, indirect enzyme-linked immunoassay 
(iELISA) for the detection of B. melitensis antibody in goat milk. Brucella salt-extractable 
protein extract (BCSP) was employed as an antigen, and a horse-radish peroxidase labeled 
polyclonal anti-goat antibody was used as an anti-species conjugate. Thirteen of 13 (I 00%) 
individual positive milk samples tested positive, and 134 of 134 ( 100%) negative bulk milk 
samples tested negative by the iELISA developed. Three positive milk samples of high, 
medium, and low titer were serially diluted in negative milk to simulate one positive animal 
in a negative herd. By this estimation, one high titer animal could be detected in a herd of 
greater than 1600 animals. Estimation for medium and low titer animals was one animal in a 
herd of less than 200 animals . The iELISA developed was found to be sensitive and specific 
and has potential for use as a bulk milk test for the detection of Brucella melitensis antibody 
in goat milk. 
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INTRODUCTION 
Bruce/la species have impacted human and animal health for thousands of years ( 102, 
21 ). They are small , non-encapsulated, non-motile, non-spore forming, Gram-negative, 
aerobic bacilli that are facultative intracellular pathogens. They cause disease in goats, cattle, 
sheep, pigs, dogs, marine mammals and a number of wild animals. Abortion is often the 
most prominent clinical sign in animals . The genus is divided along lines of host 
susceptibility including the following: Bruce/la abortus in cattle, Bruce/la melitensis in 
sheep and goats, Bruce/la suis in pigs (and some marine mammals), Brucella canis in dogs, 
Brucella neotomae in desert wood rats and Brucella ovis in sheep. Although its chronic 
intracellular nature makes eradication difficult, brucellae have been the focus of many 
national eradication programs both in the United States and abroad. The USDA plans to 
spend $9 million dollars to maintain the nearly eradicated brucellosis status in the United 
States (http: //www.usda.gov/agency/obpa/Budget-Summary/2003/master2003). The 
brucellosis situation in Mexico is much worse. The former National Commission for the 
Eradication of Bovine Tuberculosis and Brucellosis of Mexico (CONETB) spends almost 
$200 million dollars per year in eradication efforts (70). Expenditures for 2001 brucellosis 
eradication programs in the European Union (EU) exceeded $25 million dollars according to 
information on the EU website (http: / /europa.eu.int/eurlex/en/corn/pdf/200 lien _501 PC0452 
_01.pdf). 
The cost to human health is also high. Brucellosis is one of the most dangerous 
zoonoses in the world. Infectious dose estimates for humans with B. melitensis is 5000 
organisms by oral exposure or 1300 organisms by inhalation (72). Most often it is 
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manifested as an undulating fever that debilitates those infected. Upon entering the 
reticuloendothelial system the bacteria spread systemically to the spleen, liver, lymph nodes, 
joints and bone marrow and in acute cases can result in focal granulomatous lesions 
anywhere in the body. Incidence rates for brucellosis are much higher in the Mediterranean 
and Near East regions than in Northern Europe and North America, i.e. , 86.0 per 100,000 in 
Saudi Arabia versus 0.1 per 100,000 in the United States (74) . 
For all the challenges that brucellae present, much progress has been made since its 
discovery and description in the latter part of the 19th century. New vaccines are 
continuously being developed to give better protection while allowing for differentiation 
between brucellae antibody titers due to vaccine or natural infection. Fluorescence 
polarization assays (FPA) and polymerase chain reaction (PCR) are recent improvements in 
diagnostic methods. These assays are better suited to quickly and accurately detect infected 
animals than more traditional methods such as isolation and buffered brucellae antigen 
(BBA) tests. Brucellae again establishing themselves in U.S. livestock species would have 
dire consequences on animal health and economics; thus, continued progress in vaccine and 
diagnostic technology is warranted. 
The focus of this work was to develop a sensitive and specific diagnostic test for the 
detection of anti-brucellae antibodies in goat milk. The Food and Drug Administration sets 
rules governing the sale of milk for pasteurization in the United States. The rules set forth in 
the Grade "A" Pasteurized Milk Ordinance read as follows: 
Goat milk and sheep milk for pasteurization or ultra-pasteurization or aseptic 
processing shall be from a herd or flock which: 
3 
a. Has passed an annual whole herd or flock brucellosis test as 
recommended by the State Veterinarian or USDA Area Veterinarian in 
Charge (A VIC); or 
b. Has passed an initial whole herd brucellosis test, followed only by 
testing replacement animals or any animals entering the milking group 
or sold as dairy animals; or 
c. Has passed an annual random blood-testing program sufficient to 
provide a confidence level of 99% with a P value of 0.05. Any herd or 
flock with one (1) or more confirmed positive animals shall go to 
100% testing until the whole herd tests show no positive animals are 
found; or 
d. Has passed a USDA approved bulk milk test, at USDA recommended 
frequency, with an implementation date based on availability of the 
test (113). 
Although the United States has reported eradication of B. melitensis in animals since 1972 
(33), sporadic outbreaks have occurred in relation to infected imported goats from Mexico 
(120, 64). For the health of American consumers, vigilance in detection of Bruce/la species 
must continue in the goat milk industry just as it has in the bovine milk industry. According 
to the American Dairy Goat Association, there are 1,043, 91 7 registered dairy goats in the 
United States (www.adga.org/DP.htm). Diagnostic assays must be developed to handle the 
large numbers of animals to be tested on a national level, but also in a format that is 
economical and efficient for the producer. 
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Serum-based diagnostic tests are a disadvantage to goat milk producers. The first 
three options specified by the FDA for certifying goat milk brucellae-free add significant 
labor in collecting blood from individual animals. The option to test bulk milk is desirable in 
that it is convenient and economical for the producer. However, implementation depends on 
the availability of a bulk milk test that is sensitive and specific enough to ensure goat herds 
brucellae-free. To date, there have been no studies published on the development of a bulk 
milk test specifically for goats. The objective of this study was to develop an indirect 
enzyme-linked immunosorbent assay (iELISA) for the detection of anti-brucella antibody in 
goat milk samples with a focused application on bulk milk testing. 
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LITERATURE REVIEW 
History. In the 1800s, Great Britain established a naval presence on the island of 
Malta in the Mediterranean Sea. They built a "fever ward" for British personnel that 
contracted either typhoid or what was known as Mediterranean fever ( 6). In 1859, Marston 
(76) published a report on a fever that could be differentiated from that of typhoid. However, 
it was not until 1884 that Captain David Bruce was sent to investigate the cause of this 
sickness. In 1887, after isolating small micrococci from the spleen of a soldier that had died 
of the suspicious fever, he published a "Note on the discovery of a micro-organism in Malta 
fever" ( 18). The final epidemiological link was connected by Zammit, also in Malta, 
discovering that goats were the reservoir for human infection and published his work as a 
report of the newly formed Mediterranean Fever Commission in 1905 (123). A more 
complete description of events in the history of brucellosis can be found in other accounts ( 6, 
59, 73, 107). It was not long after the initial discoveries linking human infection to the goat 
reservoir that a number of investigators in France, Russia, and Japan began investigating 
brucellosis outbreaks. Major advances in isolation and diagnostic methods over many years 
have led to our current understanding of the genus Bruce Ila . 
Classification of Bruce/la melitensis. The genus Brucella falls under the sub-group 
a-Proteobacteria. They are related to a number of plant pathogens, Rhizobium and 
Agrobacterium; intracellular animal parasites, Bartonella and Rickettsia; and most closely to 
the free living Ochrabactrum (39, 83 , 114). Considerable confusion over the classification of 
different species within the genus Brucella has occurred. Taxonomists have long divided 
brucellae according to preferential hosts. The accepted nomenclature became a Brucella 
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genus divided into six species; abortus, melitensis, suis, canis, ovis and neotomae. However 
with the advent of molecular techniques, DNA-DNA hybridization showed all Brucella 
species to be very similar (62). A monospecific genus, B. melitensis, was proposed to account 
for the genetic similiarities composed of differing biovars, i.e. , B. melitensis biovar melitensis 
(115). The failure of this novel nomenclature to gain widespread acceptance has been 
attributed to dangers inherent in lumping all species together under one name. Those 
unfamiliar with the field ofbrucellae may not readily be aware of the varying pathogenicities 
of different strains if they were classified as a monospecific genus (82) . 
Disease status worldwide. Brucellosis is a global disease. Its impact on animal 
agriculture and human health has been felt for centuries. Almost all domestic livestock 
animals including sheep, goats, cattle, and swine have the potential to spread brucellosis. 
Brucella abortus is the most widespread of the Brucella species. However in human 
infection along with that of ovine and caprine species, B. melitensis plays a more important 
role. 
Historically, B. melitensis has made its greatest impact in the Mediterranean and Near 
East regions . These regions all have an agricultural environment poorly suited for extensive 
grazing giving preference to sheep and goat production over cattle. Traditional eating habits 
including consumption of unpasteurized milk and cheese along with the close proximity 
between animals and humans contributes to a high incidence of human brucellosis in the 
Mediterranean and Near East regions (74) . Although precise data concerning human 
brucellosis are hard to obtain, these areas are still considered the regions of highest 
prevalence and have seen dramatic increases in recent years. In the Near East, reports 
indicate a substantial increase in human cases of brucellosis between the years 1982 and 
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1990 in seven countries including Iran, Jordan, Kuwait, Oman, Saudi Arabia and Syria (as 
reviewed in 103 ). In 1985 there were a total of 2871 cases recorded in these countries 
increasing to a total of 82,000 by 1988. Results like this are not uncommon, as an increasing 
awareness of human infection has grown over the past 20 years. Saudi Arabia experiences 
endemic brucellosis problems with a seroprevalence rate of 15%. B. melitensis causes 88%-
93% of human cases in Saudi Arabia underscoring its relation to human infection (79). 
The most pertinent area of brucellosis infection to interests of the United States is that 
of Latin America. These regions, especially Mexico, are tied to many of the outbreaks of B. 
melitensis in the United States. There are approximately 28 million head of cattle, 7 million 
sheep and 7 million goats in Mexico (70). Sheep and goat breeding exist in areas where few 
other animals can be raised, and production practices allow for increased transmission of 
brucellosis. Mexico has 13 states with goat herd prevalence rates ranging from 11. 7% to 
63. 7%. Individual animal prevalence rates within these herds range from 2.12% to 30.49%. 
The states of Coahuila, Chihauhua, Jalisco and Zacatecas have the highest levels in tested 
herds (70). Two of these states lie on the Texas border. 
There is a correlation between human cases of brucellosis in the United States and 
proximity to the Mexican border. It has been shown that between the years 1990 to 1998 
there were 8 times as many human brucellosis cases in the four states bordering Mexico 
compared to the rest of the United States ( 44 ). This same study showed Hispanic populations 
within the U.S. at a higher risk for brucella infection. In the year 2000, there were 87 cases 
of human brucellosis in the United States. Forty-one (47%) of those occurred in either Texas 
or California (25). In general, there has been a shift in the U.S . from occupationally acquired 
brucellosis to food-borne associated brucellosis (27). Many of the recent cases of human 
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brucellosis can be traced to the ingestion of unpasteurized milk products from Mexico. The 
proximity of brucellae infected animals to the United States with the potential to spread 
human brucellosis warrants investigation into diagnostic methods that can quickly and 
effectively assess the disease status of an infected goat population. 
Pathogenesis. The most common form of transmission of B. melitensis among goats 
is the ingestion of aborted tissues from infected animals. The genus Bruce Ila is host-
dependent meaning that environmental replication does not occur and that the infectious 
cycle must include the preferred host species. Goats are nearly always infected with B. 
melitensis (2). Factors affecting the outcome of invasion include host immune response, 
level of inoculum, virulence of the bacteria, and status of pregnancy ( 50). Different from B. 
melitensis infection in sheep, there is little breed variation in susceptibility to infection. 
Frequently, the only symptom of natural infection is abortion. However, in experimentally 
affected animals with high levels of inoculum, pyrexia, weight loss, mastitis and arthritis 
have all been observed (7). As the bacteria enter the host they must cross the mucosa! barrier 
of the oropharynx or the conjuctiva. The submucosal polymorphonucleocytes (PMN) and 
eosinophils rapidly engulf those that cross the mucosal barrier. However, those that are not 
entrapped and destroyed at the site of entry will drain into the regional lymph node. 
Brucellae have the ability to resist phagolysosome fusion and primary granule release by 
macrophages and neutrophils respectively ( 14, 20, 105). After colonizing the regional lymph 
node, brucellae spread hematogenously to other organs of the reticuloendothelial system 
(RES) (3). The mammary gland and reproductive tract are other frequently colonized animal 
tissues. These localizations form focal granulomatous lesions that provide a nidus for 
recurring infections. Acute mastitis may occur in goats resulting in clotted, watery milk (50). 
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Abortion is the result of a tropism for placental trophoblasts and fetal lung occurs in the last 
trimester of pregnancy (2, 49). It has been shown that an experimental inoculation of 10 7 
CFU of B. melitensis 16M is enough to induce 70-100% fetal abortions in pregnant does 
(49). 
Host Immune Response. Resistance to invasion requires both innate and acquired 
immune systems. Complement activation by the classical pathway is known to occur. 
However at high concentrations of IgG, complement-mediated killing no longer plays a 
major role in resistance (63). As previously stated, neutrophils and macrophages are 
involved in the innate immune response to invading Brucella. Brucella's ability to escape 
destruction by these cell types allows for infection to progress. A cell-mediated acquired 
immune response is considered imperative to bacterial clearance as for other facultatively 
intracellular microorganisms (71, 85). T helper I cells and interferon-y production are 
important in the immune response to Brucella infection as well as CDS+ T cell populations 
(101, 108,122). 
Antigenic structures. Because of the close similarities in the genetic code between 
species of brucellae, antigenic structures are likewise similar. Many of the outer membrane 
and intracellular proteins have high homology between species as well as the 
lipopolysaccharide (LPS) extending from the cell membrane surface. Brucella melitensis 
like B. abortus, B. suis, and B. neotomae all posses the genes necessary in producing a 
complete LPS structure. The presence of complete LPS classifies these organisms as having 
a smooth morphology. Brucella ovis and B. canis are the only species which do not possess 
the O-polysaccharide (OPS) in LPS and are therefore classified as naturally rough species. 
10 
For those strains which are naturally smooth, there is a marked decrease in virulence when 
rough mutants are produced. 
For those species that possess it, the structure of smooth LPS (SLPS) is remarkably 
similar. They all contain OPS connected to a core oligosaccharide, 3-deoxy-2-octulosonate 
(KDO). 3-deoxy-2-octulosonate is then attached to the lipid A component embedded in the 
outer membrane. The OPS in all smooth species is a homopolymer of 4,6-dideoxy-4-
formamido-a-D-mannopyranosyl. The OPS can be either an A or M variant corresponding 
to the strain in which they were discovered, B. abortus strain 1119-3 or B. melitensis strain 
16M respectively. It was shown that the difference lies in the linkage of the homopolymer 
units (19, 119). B. abortus OPS is a 1,2-linked homopolymer. However, B. melitensis OPS 
is a pentasaccharide consisting of one 1,3-linked and four 1 ,2-linked homopolymer units. 
The classic division of the A antigen belonging to B. abortus strains and the M antigen 
belonging to B. melitensis strains no longer applies. It has been shown that different biovars 
contain different combinations of A and M antigens ( 119). 
Outer membrane proteins (OMP) have been investigated as well for their 
immunodiagnostic relevance. The initial studies identified two fractions of insoluble protein 
in a sodium dodecyl sulfate (SDS-I) cell wall extract of B. abortus (46, 47). Another fraction 
of 31-34 kDa was found in all Bruce Ila except B. abortus ( 48). The 36-38 kDa was renamed 
Omp2 and found to be a porin (43 , 55, 116). Over the course of the last 20 years, a number 
of other outer membrane proteins have been shown to be antigenic including those with 
molecular weights of 10 kDa, 16.5 kDa, 19 kDa, and 89 kDa (124). However, the immune 
response during infection against these proteins is heterogeneous; thus, they are unusable 
independently as diagnostic reagents or subunit vaccines (124 ). 
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Other Bruce/la antigens that have garnered research attention are those that are found 
in a cytosoluble protein extract (CPE). Five proteins have been found by immunoblotting to 
contribute to this fraction ' s diagnostic potential, CP12, CP24, CP28, CP32 and CP54 (41). 
CP24 has been found as an important component of Brucellin INRA (France), marketed by 
Rhone-Merieux (Brucellergene®). This mixture of 20-30 cytoplasmic proteins induces a 
delayed-type hypersensitivity (DTH) reaction in those animals that have been infected (89). 
Although vaccination with CP24 is not protective against challenge with virulent smooth 
Bruce/la (23), it may continue its usefulness in DTH testing. CP28, also reported as BP26 
and Omp28, has maintained much of the focus in this area because it is detected sooner than 
the other cellular proteins and has a higher sensitivity and specificity compared to other CPE 
antigens ( 41 ). Also, CP28 is attractive for use in diagnostic tests, as it is able to distinguish 
between Rev. I vaccinated and naturally infected animals ( 40, 28). 
Other brucellae antigens, Bruce/la salt-extractable proteins, that exist have been 
isolated from methanol-killed B. abortus cells extracted with 1 M NaCl and 0.1 M sodium 
citrate (109). Subsequent studies have shown that these are periplasmic proteins. 
Vaccination of rodent models has shown that proteins of 12, 20, and 31 kDa have a 
protective ability ( 111 ). The 31 kDa protein was especially effective in limiting infection 
and therefore has been cloned and expressed in Escherichia coli (77). This protein has been 
shown to occur in all species of Bruce/la except for B. ovis and remains highly conserved 
across species ( 17). A protein that has little variability between Bruce/la species and biovars 
is desirable for increased versatility in diagnostic tests and greater sensitivity across biovars 
of a single species of Bruce Ila . It has also been noted that BCSP3 l extracted from B. 
melitensis has a high affinity for antiserum developed in rabbits against rBCSP3 l produced 
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in E. coli. This may be the result of greater expression of BCSP31 in B. melitensis and may 
increase its immunogenicity for those host species affected. An indirect enzyme linked 
immunoassay (iELISA) has been developed using BCSP extract as an antigen for the 
detection of anti-B. abortus antibodies in cattle serum (110). 
Brucella melitensis diagnostics. To date, there have been numerous assays 
developed for the detection of brucellosis in animals. Many of the diagnostic tests have been 
developed in conjunction with eradication strategies in mind. Although largely targeted at B. 
abortus, their usefulness in detecting B. melitensis infection should be noted. Most assays 
involve the detection of antibodies directed against the SLPS. Isolation, though, remains the 
"gold standard" of definitive diagnosis (8) . Other assays detecting the presence of organism 
include polymerase chain reaction (PCR) and antigen specific enzyme-linked immunoassays. 
Culture is a desirable method of diagnosis when a species or biotype characterization 
is needed for epidemiologic reasons or confirmation is needed following detection of 
antibody. Culture techniques in brucellae isolation have been extensively described (8, 34). 
Briefly, Brucella melitensis is one of the slower growing Brucella species (5). It does not 
require CO2 or serum but does grow better upon the addition of these . Brucella. melitensis 
can be differentiated from other brucellae on the basis of its biochemical tests. It does not 
produce H2S, grows in the presence of dyes, thionin and basic fuchsin, and grows on 
erythritol, thionine blue (1 :500,000) and penicillin. Biotype I is agglutinated by 
monospecific antiserum M. Biotype 2 is agglutinated by antiserum A, and biotype 3 is 
agglutinated by both antiserum A and M (8). 
The specimens collected for culture are very important for successful isolation. The 
supramammary lymph node is the preferred tissue for sheep and goats . Submaxillary and 
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internal iliac lymph nodes are also good specimens. A piece of udder from both glands, a 
piece of uterus, and a piece of spleen are recommended as well. Milk is another specimen of 
importance to collect. As a result of its particular tropism for the uterus, brucellae may be 
found readily in the fetal membranes of an infected animal. When collecting specimen from 
the aborted fetus, fetal stomach contents are the most valuable followed by lung, spleen and 
meconium (8). 
While culture remains the "gold standard," it has a number of drawbacks. First of all, 
it is a laborious process that takes up to two weeks to complete. In the current situation of 
low prevalence, it is imperative that a timely definitive diagnosis be made. Isolation also 
requires experienced technicians familiar with brucellae. Again, in an age of low prevalence 
this is not always feasible. Lastly, the availability of needed reagents such as monospecific 
antiserum to subtype isolated brucellae is costly to maintain in the absence of widespread 
disease . Therefore, more efficient and economic methods of detection have been developed 
to detect the presence of the organism. 
Several PCR assays (86) have been developed for brucellae detection. Omp43, 16S 
rRNA, and BCSP31 are a few of the genus specific sequences used for amplification (11, 53 , 
61 ). PCR amplifying Omp43 was highly sensitive and specific detecting all Bruce Ila species 
and biovars; however, for patent reasons, they never published their sequence and hence it 
was never in widespread use. 16S rRNA PCR detects all Brucella species very well. 
However, it has been shown to cross react with a very close relative of brucellae, 
Ochobactrum anthropi. Infection with 0. anthropi is very different from that of brucellae 
and therefore easily distinguishable. BCSP3 I was the first sequence cloned and published 
for brucellae (77) . It is conserved for all species and biovars except Brucella ovis (17). 
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BCSP31 PCR has been thoroughly investigated. In one study, 98 non-brucella organisms 
tested negative and only one strain of 0. anthropi had a positive amplification (36). Species 
specific assays have been developed. (16, 29, 30, 36, 63); however, these multiplex PCR 
assays have their disadvantages in that they include a number of extra steps. It is also 
relatively difficult to find dramatic species differences in the relatively homogeneous DNA 
of Brucella. 
The ability to directly test clinical specimens would greatly aid the usability of PCR 
technology in brucellae diagnostics. However, there are many complications encountered 
because of PCR inhibitors and excessive host DNA in these specimens. Methods to 
minimize these complications have been published for aborted fetuses and fetal membranes 
(54), blood (58), milk (67, 104, 112), and semen (9). 
Diagnostic tests detecting the presence of whole cells or antigens include 
immunohistochemistry by immunofluorescence, immunoenzymatic staining or immunogold 
labeling (10, 78, 80). These assays, in general, have greater importance in the research 
community. 
There are many different formats used in anti-brucellae antibody assays. 
Agglutination assays are the cheapest and most technologically simple. Fluorescence 
polarization assay (FPA) is the most technologically advanced. Precipitin tests, complement 
fixation tests (CFT) and ELISAs both direct and competitive have been developed. Each of 
these formats has its distinct advantages and disadvantage for use in the goat species. 
Notably missing from this list of antibody detection assays for the goat is the milk 
ring test, one of the main detection assays of the U.S. brucellosis eradication program. In the 
bovine milk ring test, antibody attached to fat globules in the cream can bind hematoxylin-
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dyed brucellae. When the cream rises to the top of a positive sample, the cream layer is a 
purple color whereas the milk remains white . The milk ring test has been tried for goat milk 
in few controlled experiments and never with conclusively positive results (81 ). Because the 
fat globules in goat milk are smaller than those of bovine milk, they do not readily rise to the 
top. Thus, this simple and remarkably effective test is not available in goat milk production. 
Therefore, other assays must be relied upon to certify goat herds brucellae-free. 
The first serological test for brucellosis was described in 1897 (121 ). It was an 
agglutination assay combining whole cells and diluted serum. The serum agglutination test 
used today by the USDA is very similar to this method. One of the disadvantages of this 
assay is that nonspecific lgM is a potent agglutinator; therefore, false positives can occur. 
There have also been reports showing low sensitivity data when compared to tests such as 
CFT ( 117). The OIE manual on caprine brucellosis considers the serum agglutination test 
unreliable in small ruminants (100). Over the years, nonspecific agglutination has led to the 
development of a number of ways to limit the function of lgM in serum. These methods 
include acidified antigen, rivanol precipitation, and reducing agents. 
Acidified antigen tests were developed in the late 1960's and early 1970's. Even 
today, they are the most widely employed anti-brucellae antibody detection assays. In each 
of these assays, brucellae cells are used to agglutinate positive test serum at a pH of 3 .65. 
The low pH inhibits the agglutination by IgM and promotes agglutination by IgG1 (31, 32, 4). 
The rose-bengal/card test (RBT) (87, 84, 38), uses B. abortus S99 or 1119-3 whole cells 
stained with rose-bengal. Another detection system, the buffered plate antigen test (BP AT), 
uses B. abortus strain 1119-3 whole cells stained with crystal violet and brilliant green dyes. 
This assay has the advantage of being cheap, fast and simple. However, there are cases of 
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prozoning resulting in false negatives. Low sensitivity has been reported when compared 
with CFT ( 117). Both RBT and BPA Tare considered buffered brucellae antigen tests and 
are prescribed by the OIE as standard methods of testing for brucellosis ( I 00). 
The rivanol precipitation test uses the compound 2-ethoxy-6,9-diamino acridine 
lactate (rivanol) to precipitate high molecular weight glycoproteins such as lgM (88) . The 
resulting precipitate can be centrifuged and discarded leaving the serum to be diluted and 
subjected to a rapid agglutination test. This test is usually only used as a confirmatory test to 
rule out a non-specific lgM reaction (90) . 
Reducing agents such as 2-mercaptoethanol (106) and dithiothreitol ( 65) are another 
means of reducing the nonspecific agglutination of lgM antibodies . Reducing agents have 
the ability to disrupt disulfide bonds such as those holding the multimeric units together. The 
resulting serum is then diluted as in the rivanol test and allowed to agglutinate whole cells for 
18 hours at 3 7° C. The disadvantage of this test is that the reducing agent can affect normal 
immunoglobulin as well and destroy its binding capacity. 
Precipitin tests such as agar gel immunodiffusion (AGID) and serum radial 
immunodiffusion (SRID) assays are not as commonly employed today but have been used in 
the past for brucellosis detection. The AGID test operates on the principle of cutting two 
wells in an agar media and placing antigen in one well and test serum in an adjacent well. As 
the two diffuse through the agar, there is a concentration at which a positive test sample will 
precipitate appearing as a band in the media. The SRID is similar except that antigen is 
incorporated directly into the media. A well is cut in the agar to which test serum is added. 
As the test sample diffuses through the agar, a positive sample will reach a concentration that 
precipitates the antigen in the media appearing as a circular band around the well. A recent 
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study in Mongolia, showed that AGID performed equally as well as the CFT in goat sera and 
could be used efficaciously in combination with RBT if skilled technicians were not 
available to perform the CFT (51 ). 
Along with the buffered brucella antigen tests, the CFT is widely used in anti-brucella 
antibody detection and is prescribed for international trade by the OIE for use in sheep and 
goats . Although rather complex, it is considered an effective test for diagnosis. There exists 
differing opinion on the ability of CFT to distinguish between vaccinal antibody and 
antibody due to infection (5). It works by adding inactivated serum (heating at 56°C for 30-
60 min to destroy its own complement), antigen, and a standardized amount of complement. 
If antibody is present in the test serum, the complement will be fixed and removed from 
suspension. Sensitized red blood cells are then added. If there is still complement present, 
the red blood cells will be lysed indicating a negative test sample. The CFT is considered the 
most sensitive and specific assay for brucellae detection in sheep and goats (52). 
Although the theoretical roots for FP A have long been established, its use as a 
diagnostic tool has been a relatively new addition to the host of anti-brucellae detection 
systems (as reviewed in 93). Briefly, fluorescence polarization assays (FPA) use the 
principle that plane polarized light is emitted by a fluorescent molecule in the same plane as 
that absorbed. This is only true, however, if the molecule is stationary. Under the natural 
conditions of brownian motion, molecules are not stationary. The amount of scattering of the 
plane polarized light is inversely proportional to the size of the molecule. In other words, 
smaller molecules rotate to a greater degree during their emission phase of polarized light 
than larger ones. If a baseline of polarization is established with an antigen conjugated with 
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a fluorescent molecule, the presence of antibody binding to the antigen can be detected by a 
difference in the amount of light scattering. Fluorescent polarization assay was first adapted 
to brucellae testing in 1996 (94). For detection of brucellae antibody, fluorescein 
isothiocyanate (FITC) is conjugated to a 20-30 kDa B. abortus O-polysaccharide. 
Fluorescence of this conjugated molecule will result in less polarization than that of the same 
molecule bound to anti-brucella antibody. Sample specimens are compared to strong 
positive, weak positive, and negative control serum. In the initial trial by Nielsen, they 
obtained sensitivity and specificity of 99.02% and 99.96% respectively after testing sera from 
8669 negative cattle, 561 positive cattle, and 250 B. abortus strain 19 vaccinated cattle. All 
of the 250 sera from vaccinated cattle tested negative. This same procedure was applied to 
bovine milk samples with positive results. 
Fluorescent polarization assay has many advantages over other antibody binding 
assays. It is very fast only requiring time for the antibody-antigen complexes to form. It is 
readily portable allowing for testing in field situations, and it gives very sensitive and 
specific results. For cattle, FPA is listed as an alternative test for brucellosis determination in 
international trade ( l 00). It has recently been validated in Mexico for testing of cattle sera 
(70) and is being validated in that country for use in goat serum and bovine milk (37, 93). To 
date, there have been few formal studies regarding the applicability of FPA to B. melitensis 
diagnostics. However, using the similarities in structure of the O-polysaccharide of B. 
melitensis and B. abortus as an indication, this method is theoretically feasible. 
By using monoclonal antibodies, competitive ELISAs (cELISA) have been developed 
to distinguish between antibody titer as a result of vaccination or infection (56, 75, 95). The 
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concept is for high affinity monoclonal antibodies to bind more tightly than lower affinity 
vaccinal antibodies. While specificity is seen to increase with this method, sensitivity 
decreases (75). Another disadvantage is obtaining sufficient quantities of monoclonal 
antibodies to perform the test. Also, in the U.S. very little vaccination occurs for sheep and 
goat brucellosis, and therefore the increase in specificity is unjustified. 
The iELISA has been applied to brucellae diagnostics by a number of researchers 
primarily for B. abortus (as reviewed in 92). A variety of antigens have been used for 
detection of anti-brucellae antibodies in the iELISA format including SLPS (22, 66), native 
hapten (1), BP26 (28), cytoplasmic proteins (24, 68), all major and minor OMPs (124), and 
brucella salt-extractable proteins (110). Smooth lipopolysaccharide has been the primary 
antigen evaluated and has been used in large scale studies to determine the effectiveness of 
this method in cattle. With the added dimension of using calcium chelating agents, 
sensitivity and specificity values have been reported as high as 100% and 99%, respectively, 
in testing individual animals (96). However, there still remains the possibility of false 
positive results because of cross-reactions between Yersinia, Escherichia, Vibrio, 
Pseudomonas and Salmonella species (26). Instability under long-term storage has also been 
reported when using SLPS as an antigen (L.B. Tabatabai, personal communication). Also, 
the B. abortus SLPS ELISA is not a proficient test in detecting IgM, limiting its use in early 
detection of infection ( 66, 97). There is also a decrease in performance of the LPS ELISA 
due to a lack of standardized antigen and test serum preparations (97). 
There have been only a few studies investigating brucellosis in goats using SLPS 
iELISA ( 42, 81 ). One study in goat sera found sensitivities ranging from 60% to 90% over a 
24-week period of infection in a limited number of animals (81 ). In the same study, an 
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iELISA was performed on goat milk collected every two weeks following parturition with 
sensitivity data ranging from 86% to 100%. 
BCSP is another antigen extract that has been used in iELISA ( 110). In a limited 
study, 7 cattle experimentally challenged with B. abortus were all positively identified. Out 
of 103 negative serum samples tested, 2% initially were false positives. However, after four 
months, all of the false-positive animals no longer tested positive. 
There are advantages to using BCSP over LPS . One, it is very stable under long-term 
storage. Second, it shows very little cross-reaction with other pathogens with similar 
structure to LPS. Third, the concentration needed to coat the wells of a microtiter plate is 
very small, less than 1 µg/mL concentration (I 10). 
The clinical specimens used for investigating most iELISA formats have been sera. 
However, for the LPS iELISA there are studies using milk specimens from sheep and goats 
with B. melitensis (81 , 15). Extensive studies using cow milk have only been done for cattle 
with B. abortus (98). 
Summary. A sensitive and specific diagnostic assay for use on a national scale that 
is economical and efficient for producers is needed for goat brucellae diagnostics. A bulk 
milk test for use in certifying goat herds brucellosis-free is desirable . However, specificity 
must be very high to limit the number of false-positives to be investigated. BCSP is an 
extract that has been shown to be specific for brucellae in cattle and therefore shows promise 
in the detection of B. melitensis in goats. The iELISA methodology has been proven to be 
effective in the detection of minute quantities of antibodies in clinical specimens and has not 
been sufficiently evaluated in B. melitensis diagnostics of goat milk. The following describes 
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the development of an iELISA using BCSP for the detection of B. melitensis antibody in goat 
milk. 
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MATERIALS AND METHODS 
Antigen Preparation. Whole cell sonicate (WCS) was prepared from heat-killed B. 
melitensis strain 16M (National Veterinary Services Laboratories, Ames, IA). Cells were 
sonicated at 30 Hz for 15 min with a Branson Sonifier 250 (Branson Ultrasonics Corp. , 
Danbury, CT). 
Brucella cell surface proteins were prepared as described previously (109). 
Methanol-killed Bruce/la abortus strain 1119-3 cells were combined with 1 M NaCl-0.1 M 
Na-citrate (0.2 gm per ml) and stirred overnight at 5° C. The suspension was centrifuged at 
10,000 x g at 5° C for 20 min. This process was repeated, and the supernatants were 
combined and dialyzed against 100 volumes of 5 mM NH4HCO3. The supernatant was again 
centrifuged at 10,000 x g for 30 min at 5° C and precipitated with solid (NH4) 2SO4 at 70% 
saturation for 16 hat 5° C. Then precipitate was centrifuged at 15,000 xg , reconstituted in 
minimal volume of 5 mM NH4HCO3 and dialyzed against 100 volumes of 5 mM NH4HCO3. 
The resulting solution was freeze-dried and adjusted to a concentration of 1.0 mg protein/mL 
and stored at -70° C. Protein, carbohydrate, and KDO were measured as described (69, 45 , 
118, 110). 
Animal Inoculation. Sixteen female goats were inoculated with 50 µl of 1 x 107 
CFU of Bruce/la melitensis strain 16M in the conjunctival sac. This work was carried out at 
the Louisiana State University Agricultural Center. Mean time to necropsy was 37 d (range 
15-49). Bruce/la melitensis strain 16M was isolated from tissues of all infected goat, and all 
goats were serologically positive by the card test (8) . 
23 
Milk Samples. Positive milk samples from experimentally infected animals, both 
card test positive and culture positive, were obtained at necropsy from inoculated goats. 
Sixteen positive milk samples were received from Louisiana State University Agricultural 
Center. Three mucoid samples were not used because their consistency made precise volume 
measurements impossible. Twelve of 13 milk samples were culture positive. One-half 
milliliter of each positive sample was combined for use as a pooled positive control when 
testing negative milk for assay specificity. 
Negative milk used for specificity determination came from bulk milk samples 
obtained from 134 brucellae negative goat herds in the U.S. (Wisconsin (69), California (30), 
Vermont (21), Michigan (7), New York (7)). Herd size ranged from 20 to 1200 animals 
(median= 95). These samples were assumed to be brucellae-negative as B. melitensis has 
been eradicated from the U.S. since 1972 (33), and there was no history of chronic abortions 
in any herd. A pooled milk sample from 3 individual healthy goats was used as a negative 
control throughout the experiment. The cream was separated and removed from all milk 
samples before testing by centrifugation at 2,000 x g for 20 min. 
Indirect ELISA (iELISA) for antibody in milk. The iELISA procedure was 
performed as previously described (110). Briefly, 96-well plates (Nalge Nunc International, 
Rochester, NY) were coated with 100 µl of 0.1 µg/ml of either BCSP or WCS suspended in 
0.05 M Na2CO3 and incubated overnight at 5° C. Plates were washed 5 times with 0.1 M 
phosphate-buffered saline plus 0.05% Tween-80 (PBST) (Difeo Laboratories, Detroit, MI) 
for 5 min each time. One hundred µl of milk were diluted 1/100 in PBST or serially diluted 
in negative milk and incubated for 2 hours at room temperature. Plates were again washed 
with PBST as described earlier. One hundred µl of horseradish peroxidase conjugated rabbit 
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polyclonal anti-goat IgG (H+L) antibody (Bethyl Laboratories, Inc. , Montgomery, TX) then 
were added at 1/2000 dilution to all wells on the plate. Plates were again incubated for 2 hat 
room temperature or overnight at 5° C. Plates were then washed with PBST and a single 
wash of distilled water before a substrate solution consisting of 0.2 mM ABTS (2 ,2 ' -azino-
di-(3-ethyl-benzthiazoline-6-sulfonic acid)) (Sigma Chemical Co. , St. Louis, Mo.), and 5 mM 
H2O2 (0 .015%) in 50 mM citrate buffer (pH 4.0) was added to produce a color change. The 
reaction was stopped after 10 min with 1 mM sodium azide. A plate reader (Bio-tek 
Instruments, Winooski, VT) was used to read absorbance at 492 nm. All samples were run in 
duplicate trials with the average absorbance reported. Antigen, milk sample, and anti-species 
conjugate were titrated for optimal assay performance. 
Positive Bulk Milk Simulation. To simulate the presence of one positive animal in a 
bulk milk sample, high, medium, and low titer positive milk samples were chosen and diluted 
serially in negative milk. The resulting dilution was tested at a l /1 0 dilution in PBST, and 
the average of two separate trials absorbance were reported. This estimation assumes equal 
volumes of milk produced by infected and noninfected goats. 
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RESULTS 
Chemical Assays. BCSP extract and WCS were both investigated for their ability to 
bind brucellae antibody in infected goat milk. Results of the chemical assays performed on 
BCSP and WCS are presented in Table 1. When expressed as a ratio of protein 
concentration, both KDO content and carbohydrate were higher for the BCSP antigen than 
WCS. 
Table 1. Chemical Assays. Carbohydrate and 2-keto-3-deoxyoctulonsonic acid (KDO) 
ratios of whole cell sonicate (WCS) and Brucella salt-extractable proteins (BCSP) to protein 
concentration. 
Antigens 
BCSP 
wcs 
Carbohydrate/ protein (mg/mg) 
0.31 
0.014 
KDO/ protein (µg /mg) 
7.86 
4.83 
Comparison of BCSP and WCS antigens. There was a marked difference in the 
antibody present in pooled positive milk against BCSP compared with WCS (Fig. 1 ). 
Maximal absorbance from pooled positive milk sample using BCSP was 0.8 units absorbance 
compared with 0.4 units using WCS. Titration kinetics with positive pooled milk using 
BCSP showed a greater change in absorbance as a function of milk dilution than that of 
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WCS. Titration kinetics with the negative pooled milk was very similar for both BCSP and 
WCS. Only BCSP was used in determining sensitivity and specificity. 
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FIGURE 1. Comparison of Brucella salt-extractable protein antigen (BCSP) and whole cell 
sonicate (WCS). Anti-brucellae antibody responses were compared by iELISA using pooled 
positive milk (BCSP •, WCS A) and negative control milk samples (BCSP c , WCS x). 
Sensitivity and specificity. A 1/1 00 dilution of individual positive and negative milk 
samples were tested in duplicate by iELISA and absorbance values plotted (Fig. 2) . Average 
positive absorbance was 0.62 (CI 0.49 to 0. 75 alpha= 0.99). Average negative absorbance 
was 0.0025 (Cl 0.0013 to 0.0038 alpha= 0.99). The absorbance values for the negative 
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samples were skewed toward zero with a median negative absorbance of 0.0. To maximize 
specificity and maintain sensitivity, a positive/negative cutoff of 0.1 absorbance units was 
chosen. BCSP iELISA detected all of the individual positive samples (n=13) and did not 
detect antibody in any of the negative samples (n= 134) (Fig. 2). Because there was a large 
difference between the absorbance of positive and negative milk sample, a receiver operator 
characteristic (ROC) curve was not performed as is commonly done to optimize an assay. It 
is significant to note that this assay correctly identified one milk sample that was not culture 
positive. 
Bulk milk simulation. To assess the ability of this assay to detect antibody in bulk 
milk, three positive samples (high, medium, and low) were chosen from the individual milk 
samples and serially diluted in negative milk and tested at a 1/10 dilution in PBST. The high 
positive was readily detected to a titer of 1/1 600. The medium and low positive samples 
maintained a positive titer to 1/200 and 1/50 dilutions respectively. 
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FIGURE 2. Milk iELISA results. Absorbance data for milk samples from 13 experimentally 
infected goats ( •) and 134 bulk milk samples from noninfected goat herds ( • ). Milk samples 
were tested in duplicate at 1/100 dilution in PBST. Horizontal line indicates 
positive/negative cutoff. 
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FIGURE 3. Bulk milk simulation. iELISA-positive milk samples of high(~), medium(•) , 
or low ( •) antibody titer were diluted in the negative control milk and then tested in duplicate 
at 1: 10 dilution in PBST. 
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DISCUSSION 
The objective of this study was to develop a sensitive and specific diagnostic test for 
the detection of B. melitensis antibody in goat milk with a focused application for testing 
bulk milk samples. BCSP has previously been shown in other investigations to be a specific 
antigen in detecting brucellae antibody in serum (110). Nonspecific antibody in uninfected 
animals against brucellae LPS has been shown for a number of different pathogens including 
Escherichia coli, Yersinia enterocolitica, and Pseudomonas solanacearum (66, 91 , 99). 
Lipopolysaccharide is commonly used as an antigen in most iELISA formats (92). While the 
presence of LPS present in this extract cannot be ruled out (see Table 1 ), the BCSP extract 
used in this iELISA was based on protein content. The results show that no false positives 
were encountered in the milk of uninfected bulk milk samples when tested by BCSP iELISA. 
It should be noted that bulk milk samples were used instead of individual milk 
samples to determine specificity. The primary application for development of this iELISA 
was for bulk milk use, and therefore, bulk milk was used instead of individual milk samples. 
Also, because of the ease of collection, a large number of herd samples were obtained from 
many different areas in the U.S. representing over 22,000 animals. There was no difference 
noted in the response of uninfected bulk milk samples to that of the individual animals used 
in making up the pooled negative control. However, the possibility remains that nonspecific 
antibody could have been diluted in bulk milk, and therefore, the absorbance for false 
positives fell below the limits of detection. More milk samples from individual animals 
would be required if this test was to be evaluated for use on individual animals. 
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The cutoff for positive and negative samples was determined by assessing the 
implications for false positive and false negative results. Other more empirical methods have 
been used to set positive/negative cutoff values (12, 35 , 57). Because of the wide separation 
of responses between positive and negative samples, the cutoff was set at a higher 
absorbance than would be calculated by most methods to increase specificity without 
lowering sensitivity. This assay was developed for use in the U.S., which is a low prevalence 
region. In this situation, false positives are of greater concern than false negatives making a 
greater specificity beneficial. A receiver operator characteristic (ROC) curve was not needed 
to optimize sensitivity and specificity as there were no false positive or false negative sample 
responses. 
To determine the sensitivity of the assay, 13 milk samples were used from infected 
goats with B. melitensis strain 16M. Western blotting has shown a strong antibody response 
against BCSP during infection with B. abortus and B. melitensis in cattle and goats 
respectively (13 , Appendix B.). BCSP also has been shown to be effective in detecting B. 
abortus in cattle by iELISA (110). Figure 2 shows that goats infected experimentally with B. 
melitensis produce antibody against BCSP and that noninfected goats do not. 
Because of the scarcity of milk samples from goats naturally infected with B. 
melitensis in the United States, samples from experimentally infected goats were used. It is 
noted that the antigenic response under experimental conditions may not be equivalent to that 
seen under natural infection. However, the experimentally infected goats were inoculated 
with a dose of 1 x 10 7 CFU B. melitensis strain 16M which has been shown to consistently 
infect goats and induce abortions ( 49). These experimentally infected goats showed high 
immune response to an antigen prepared from B. abortus strain 1119-3 indicating conserved 
32 
antigenic elements between species and strains which may be encountered under natural 
conditions. It is therefore predicted that antibody response to BCSP under natural infection 
conditions with B. melitensis would be similar to those experimentally produced. 
Bulk milk from herds naturally infected with B. melitensis were not available, thus 
simulated bulk milk samples containing one positive animal of high, medium or low antibody 
titer were used. For ease of estimation, it was assumed that equal volumes of milk are 
produced by infected and noninfected animals. Figure 3 shows that one animal of high titer 
would be detected in a bulk milk sample from herds with greater than 1600 animals. This 
number of animals is greater than most herd sizes in the U.S. However, if infection produces 
only a medium or low titer, the ability to detect an infected animal would be limited to a herd 
size of around 200 animals or less . On the basis ofresults in Fig. 3, it is recommended that 
large herds be sampled in groups of 50 animals or less for bulk milk testing. 
An unknown factor acknowledged in this study pertains to the duration of antibody 
response. The positive milk samples were collected from experimentally infected animals at 
necropsy ranging from 15-49 days post infection. It is not known how long a positive titer is 
maintained after infection, and therefore, further study would be needed to determine the 
frequency of bulk milk testing needed to ensure that brucellae-infected herds are detected 
before infection spreads through the herd. 
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CONCLUSIONS 
To ensure the goat industry in the United States remains brucellae-free, adequate 
steps must be taken to certify goat herds free of brucellosis. As it stands today, diagnostic 
efforts are hindered by serum-based detection methods that incur added labor and animal 
stress. The iELISA described can be considered a feasibility study in the process of 
development and validation of a sensitive and specific diagnostic test for B. melitensis 
antibody in goat milk. Individual milk samples from experimentally positive animals were 
shown to test positive (13/13), and bulk milk samples from brucellae-free herds were shown 
to test negative ( 134/134 ). The estimate of herd size that would allow the detection of one 
positive animal in a bulk milk sample was also a positive indication that this test may have 
potential application for bulk milk testing. Collectively, these results justify further 
investigation in goat milk diagnostics of B. melitensis using the BCSP iELISA format. 
One aspect of future study includes determining how BCSP antigen compares with 
other antigens that have been used in serum iELISA tests including cytosoluble protein 
extract, outer membrane proteins, and smooth lipopolysaccharide. A comparison study 
would involve the preparation of these antigens under the techniques already described ( 40, 
124, 96) and optimizing their use for milk specimens. An experimental iELISA, HerdChek® 
Brucella abortus antibody test kit (IDEXX Laboratories, Westbrook, ME) using SLPS for the 
detection of B. melitensis antibody in goat milk has been reported (81 ). A comparison of 
results from the BCSP iELISA and SLPS iELISA testing the same experimentally infected 
samples would be interesting in determining antigen superiority. 
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APPENDIX A. ADDITIONAL FIGURES 
Optimization of iELISA. The iELISA developed was titrated for optimization of 
antigen and conjugate dilution. Dilution chosen was at the end of the saturated plateau of the 
curve. This point allowed for maximal assay performance without wasting antigen or 
conjugate. 
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FIGURE A. Conjugate titration. Titration of horseradish peroxidase conjugated rabbit anti-
goat IgG (H+L) using a 1: 100 dilution of B. melitensis positive control goat milk. Data 
points are an average of 2 replicates. A 1: 100 dilution of the negative control at a conjugate 
dilution of 1 :2000 showed an absorbance of 0.08 (data not shown). 
35 
0 .9 
0.8 -
0.7 -
0.6 -
E 
C: 
"' 
"' 0.5 -::!. 
Cl) 
" C: 
ell 
.Q 0.4 -.. 
0 
(J) 
.Q 
ct 
0.3 -
0.2 -
0.1 7 
0 
0.1 0.01 0.001 0.0001 0.00001 
Antigen Dilution (microgm/ml protein) 
FIGURE B. Antigen titration. Titration of Brucella salt-extractable protein (BCSP) antigen 
using varying positive control goat milk dilutions including 1 :200 (•), 1 :400 (~), 1 :800 (x), 
1:1600 (*), 1:3200 (•). 
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FIGURE C. Milk titration. Titration of positive and negative control goat milk using 0.1 
µg/ml of BCSP and a 1 :2000 dilution of horseradish peroxidase conjugated rabbit anti-goat 
polyclonal lgG (H+L). Each point represents the average of 5 independent replicates. 
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APPENDIX B. SUPPLEMENT AL DAT A 
Western blot and SDS-PAGE of BCSP. The antibody response in milk of infected 
goats to the proteins in BCSP was characterized using previously described methods ( 13 ). 
SDS-PAGE showed protein bands of 34 kDa, 43 kDa, 4 7 kDa, and 64 kDa (Fig. C, lane 7). 
Positive goat milk contained antibody to all four proteins in the low and high positive 
animals (Fig. C, lanes 3-4, and 5-6, respectively), but negative goat milk did not have 
antibody to any proteins in BCSP (Fig. C, lanes 1 and 2). 
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FIGURE C. SDS-PAGE and western blot ofBCSP. SDS-PAGE ofBCSP (lane 7) and 
molecular weight standards (lane 8). Western blot of Brucella salt-extractable proteins 
(BCSP) and goat milk from negative control animals (lanes 1,2), a low positive animal (lane 
3,4), and a high positive animal (lane 5,6). Each lane contained 5.5 µg of BCSP. 
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